These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 25729033

  • 1. Anti-dsDNA and Antichromatin Antibody Isotypes in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus.
    Steiman AJ, Urowitz MB, Ibañez D, Li TT, Gladman DD, Wither J.
    J Rheumatol; 2015 May; 42(5):810-6. PubMed ID: 25729033
    [Abstract] [Full Text] [Related]

  • 2. Association of antinucleosome antibodies with disease flare in serologically active clinically quiescent patients with systemic lupus erythematosus.
    Ng KP, Manson JJ, Rahman A, Isenberg DA.
    Arthritis Rheum; 2006 Dec 15; 55(6):900-4. PubMed ID: 17139667
    [Abstract] [Full Text] [Related]

  • 3. Lack of Interferon and Proinflammatory Cyto/chemokines in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus.
    Steiman AJ, Gladman DD, Ibañez D, Noamani B, Landolt-Marticorena C, Urowitz MB, Wither JE.
    J Rheumatol; 2015 Dec 15; 42(12):2318-26. PubMed ID: 26568589
    [Abstract] [Full Text] [Related]

  • 4. Follow-up and management of serologically active clinically quiescent cases in pediatric systemic lupus erythematosus.
    Capone G, Lojacono C, Al-Bayitee F, Makvandi S, Hennon T, Wrotniak B, Abdul-Aziz R.
    Reumatologia; 2021 Dec 15; 59(4):244-251. PubMed ID: 34538955
    [Abstract] [Full Text] [Related]

  • 5. Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease.
    Villalta D, Bizzaro N, Bassi N, Zen M, Gatto M, Ghirardello A, Iaccarino L, Punzi L, Doria A.
    PLoS One; 2013 Dec 15; 8(8):e71458. PubMed ID: 23951169
    [Abstract] [Full Text] [Related]

  • 6. The antichromatin antibodies can be useful as a diagnostic tool and disease activity marker of systemic lupus erythematosus in Koreans.
    Kim HA, Jeon JY, Choi GS, Sung JM, Kim MJ, Yun JM, Suh CH.
    Clin Immunol; 2008 Aug 15; 128(2):277-83. PubMed ID: 18504161
    [Abstract] [Full Text] [Related]

  • 7. Outcomes in patients with systemic lupus erythematosus with and without a prolonged serologically active clinically quiescent period.
    Steiman AJ, Gladman DD, Ibañez D, Urowitz MB.
    Arthritis Care Res (Hoboken); 2012 Apr 15; 64(4):511-8. PubMed ID: 22162433
    [Abstract] [Full Text] [Related]

  • 8. Anti-Double-Stranded DNA Isotypes and Anti-C1q Antibody Improve the Diagnostic Specificity of Systemic Lupus Erythematosus.
    Jia Y, Zhao L, Wang C, Shang J, Miao Y, Dong Y, Zhao Z.
    Dis Markers; 2018 Apr 15; 2018():4528547. PubMed ID: 30363714
    [Abstract] [Full Text] [Related]

  • 9. Selective adsorption of antiphospholipid and anti-dsDNA autoantibodies on histidine based pseudobioaffinity adsorbent from sera of patients with systemic lupus erythematosus (SLE).
    Zeinab M, Hiam KM, Edmond C, Assem E.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jan 15; 975():77-83. PubMed ID: 25438246
    [Abstract] [Full Text] [Related]

  • 10. Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis.
    Förger F, Matthias T, Oppermann M, Becker H, Helmke K.
    Lupus; 2004 Jan 15; 13(1):36-44. PubMed ID: 14870916
    [Abstract] [Full Text] [Related]

  • 11. BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus.
    Bardin N, Desplat-Jego S, Daniel L, Jourde Chiche N, Sanmarco M.
    Autoimmunity; 2009 Jan 15; 42(1):63-8. PubMed ID: 19127456
    [Abstract] [Full Text] [Related]

  • 12. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A, Sis J, Max R, Mueller K, Fiehn C, Zeier M, Andrassy K.
    Scand J Rheumatol; 2007 Jan 15; 36(4):291-8. PubMed ID: 17763207
    [Abstract] [Full Text] [Related]

  • 13. Constant isotype pattern of anti-dsDNA antibodies in patients with systemic lupus erythematosus.
    Winkler TH, Henschel TA, Kalies I, Baenkler HW, Skvaril F, Kalden JR.
    Clin Exp Immunol; 1988 Jun 15; 72(3):434-9. PubMed ID: 3262461
    [Abstract] [Full Text] [Related]

  • 14. Treatments and outcomes in Chinese patients with serologically active clinically quiescent systemic lupus erythematosus: a retrospective observational study.
    Huang H, Mu L, Zhang Z, Gao D, Hao Y, Zhou W.
    Arthritis Res Ther; 2021 Oct 29; 23(1):275. PubMed ID: 34715915
    [Abstract] [Full Text] [Related]

  • 15. Serologically active clinically quiescent systemic lupus erythematosus--predictors of clinical flares.
    Walz LeBlanc BA, Gladman DD, Urowitz MB.
    J Rheumatol; 1994 Dec 29; 21(12):2239-41. PubMed ID: 7699623
    [Abstract] [Full Text] [Related]

  • 16. The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: findings of a prospective, randomized, double-blind, placebo-controlled trial.
    Tseng CE, Buyon JP, Kim M, Belmont HM, Mackay M, Diamond B, Marder G, Rosenthal P, Haines K, Ilie V, Abramson SB.
    Arthritis Rheum; 2006 Nov 29; 54(11):3623-32. PubMed ID: 17075807
    [Abstract] [Full Text] [Related]

  • 17. Antibody clustering helps refine lupus prognosis.
    Kessel A, Rosner I, Halasz K, Grushko G, Shoenfeld Y, Paran D, Toubi E.
    Semin Arthritis Rheum; 2009 Aug 29; 39(1):66-70. PubMed ID: 18538829
    [Abstract] [Full Text] [Related]

  • 18. Progressive reduction of serum complement levels: a risk factor for relapse in patients with hypocomplementemia in systemic lupus erythematosus.
    Miyawaki Y, Sada K, Asano Y, Hayashi K, Yamamura Y, Hiramatsu S, Ohashi K, Morishita M, Watanabe H, Matsumoto Y, Kawabata T, Wada J.
    Lupus; 2018 Nov 29; 27(13):2093-2100. PubMed ID: 30309286
    [Abstract] [Full Text] [Related]

  • 19. Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus.
    Mok CC, Ho LY, Leung HW, Wong LG.
    Transl Res; 2010 Dec 29; 156(6):320-5. PubMed ID: 21078493
    [Abstract] [Full Text] [Related]

  • 20. Flare, persistently active disease, and serologically active clinically quiescent disease in systemic lupus erythematosus: a 2-year follow-up study.
    Conti F, Ceccarelli F, Perricone C, Miranda F, Truglia S, Massaro L, Pacucci VA, Conti V, Bartosiewicz I, Spinelli FR, Alessandri C, Valesini G.
    PLoS One; 2012 Dec 29; 7(9):e45934. PubMed ID: 23029327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.